MedPanel

Views & Analysis

New survey data from MedPanel, compiled exclusively for pharmaphorum, has revealed US physicians’ thoughts on the topics set to dominate ASCO.

R&D

Where do doctors see patients with rare diseases, how do they keep up with treatment advances and what can pharmaceutical companies do to help?

Oncology

At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.